89912-57-2 Usage
Chemical structure
A complex compound consisting of a pyrazolo[3,4-b]quinoxalin ring system with a butane-1,2,3,4-tetrol side chain attached.
Functional groups
Contains multiple functional groups, including a butane chain, a 3,4-dihydro-1H-pyrazolo group, and a 4-methylphenyl group.
Molecular weight
Approximately 460.5 g/mol
Appearance
Likely a solid, due to the presence of multiple polar functional groups and hydrogen bonding potential.
Solubility
Expected to be soluble in polar solvents such as water, methanol, or ethanol, due to the presence of hydroxyl and amine groups.
Stability
May be sensitive to heat, light, or acidic/basic conditions due to the presence of multiple functional groups.
Synthetic methods
The compound is a synthetic chemical compound, likely synthesized through a series of chemical reactions involving the formation of the pyrazolo[3,4-b]quinoxalin ring system and the attachment of the butane-1,2,3,4-tetrol side chain.
Potential applications
Has potential applications in various fields, including pharmaceuticals, materials science, and organic chemistry, due to its complex structure and multiple functional groups.
Research interest
The detailed structure and properties of the compound make it a subject of interest for further research and development, particularly in understanding its potential applications and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 89912-57-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,9,1 and 2 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 89912-57:
(7*8)+(6*9)+(5*9)+(4*1)+(3*2)+(2*5)+(1*7)=182
182 % 10 = 2
So 89912-57-2 is a valid CAS Registry Number.
89912-57-2Relevant articles and documents
3-&β-D-ERYTHROFURANOSYL-6,7-DIMETHYL-1-p-TOLYL- AND -1-(p-CHLOROPHENYL-PYRAZOLO(3,4-b)QUINOXALINE C-NUCLEOSIDE ANALOGS
Sallam, Mohammed A. E.,Abdel Megid, Somia M. E.
, p. 85 - 96 (2007/10/02)
The C-nucleoside analogs 3-β-D-erythrofuranosyl-6.7-dimethyl-1-p-tolyl-pyrazolo(3,4-b)quinoxaline (5) and 1-(p-chlorophenyl)-3-β-D-erythrofuranosyl-6,7-dimethylpyrazolo(3,4-b)quinoxaline (7) were prepared by the dehydrativ cyclization of the polyhydroxyal
